INTERNATIONAL PATENT: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT FILES APPLICATION FOR "A HUMANIZED MONOCLONAL ANTIBODY TO SFRP2 FOR TUMOR ASSOCIATED MACROPHAGE REDUCTION AND POLARIZATION IN CANCER"

GENEVA, Oct. 1 -- MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (135 Cannon Street, Suite 101LCharleston, SC 29425) filed a patent application (PCT/US2025/020662) for "A HUMANIZED MONOCLONAL ANTIBODY TO SFRP2 FOR TUMOR ASSOCIATED MACROPHAGE REDUCTION AND POLARIZATION IN CANCER" on Mar 20, 2025. With publication no. WO/2025/199292, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEMORE, Nancy (1461 Appling DriveMt. Pleasant, SC 29464), HSU, Lillian (135 Cannon Street, Suite 101LCharleston, SC 29425), NASARRE, Patrick (135 Canno...